Randomised phase II study of the combination of oral vinorelbine with capecitabine versus gemcitabine in combination with paclitaxel versus gemcitabine in combination with docetaxelchemotherapy in patients with metastatic breast cancer.
Randomised phase II study of the combination of oral vinorelbine with capecitabine versus gemcitabine in combination with paclitaxel versus gemcitabine in combination with docetaxelchemotherapy in patients with metastatic breast cancer.
Study of Oral Vinorelbine Plus Capecitabine Versus Taxane-gemcitabine Combinations as 1st Line Chemotherapy in Metastatic Breast Cancer
Randomised phase II study of the combination of oral vinorelbine with capecitabine versus gemcitabine in combination with paclitaxel versus gemcitabine in combination with docetaxelchemotherapy in patients with metastatic breast cancer.
Statut
Status :
Terminé
Type d'étude
Phase II
Age Min.
18
Ans
Age Max.
-
Genre
Femme
Aire thérapeutique :
Oncologie
Maladie :
Cancer du sein métastatique
Traitement :
Vinorelbine (Navelbine® Oral)
Phase :
Phase II
Date de début de l'étude :
27 Mars 2006
End date :
28 Juin 2013
Identifiant de l'essai :
PM0259 CA 223 B0
Identifiant EudraCT/CTIS :
2005-000438-19
Identifiant CT.gov :
NCT03887130
Envoyer par email